Know Cancer

or
forgot password

Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.


N/A
18 Years
N/A
Open (Enrolling)
Both
Bladder Cancer

Thank you

Trial Information

Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.


Inclusion Criteria:



- Patients with bladder tumors and patients with benign urinary tract conditions with
no clinical suspicion of bladder cancer.

Exclusion Criteria:

- Patients with competing urinary and systemic diseases, pregnant and patients under 18
years of age.

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Primary Purpose: Screening, Time Perspective: Longitudinal, Time Perspective: Prospective

Principal Investigator

Reza R Serizawa, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Copenhagen University Hospital at Herlev

Authority:

Denmark: Danish Medicines Agency

Study ID:

Blæretumor PCR projekt

NCT ID:

NCT00244205

Start Date:

November 2005

Completion Date:

Related Keywords:

  • Bladder Cancer
  • Urinary Bladder Neoplasms

Name

Location